title: Pharmacokinetics of ciprofloxacin in sheep after single intravenous or intramuscular administration.
abstract: The disposition and urinary excretion of ciprofloxacin (CIP) following intravenous (IV) or intramuscular (IM) administration of 7.5 mg/kg body weight in sheep (n = 5) was studied. The intravenous plasma concentration curve was best described pharmacokinetically by a two-compartment open model, while the intramuscular administration data fitted better to a one-compartment open model. Mean elimination half-lives after IV and IM administration were 72 and 184 minutes, respectively. The absorption of intramuscularly administered CIP in sheep was fast: maximal plasma concentration (Cmax) was reached quickly (tmax 31.93 min) and attained values of 0.69 +/- 0.27 mg/l. The bioavailability was 49%. The urinary data showed a significant decrease in the elimination rate constant of CIP when CIP was administered intramuscularly. The other parameters calculated did not display differences between the two routes of administration. The results obtained suggest that when CIP was administered by the IM route in the assayed dose, it was able to maintain serum concentrations above the MIC of most common pathogens over an 8-hour period.
authors.affiliation: Department of Pharmacology, Veterinary School, University of Zaragoza, Spain.
authors.forename: M J
authors.initials: MJ
authors.lastname: Munoz
authors.forename: P
authors.initials: P
authors.lastname: Llovería
authors.forename: M P
authors.initials: MP
authors.lastname: Santos
authors.forename: A R
authors.initials: AR
authors.lastname: Abadía
authors.forename: J J
authors.initials: JJ
authors.lastname: Aramayona
authors.forename: M A
authors.initials: MA
authors.lastname: Bregante
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000652:urine; D001682:Biological Availability; D001835:Body Weight / Q000502:physiology; D002851:Chromatography, High Pressure Liquid / Q000662:veterinary; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000652:urine; D004334:Drug Administration Schedule; D005260:Female; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D012756:Sheep / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D013997:Time Factors
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin